Mobius Therapeutics

The Mobius Leadership Team

Mobius was founded in 2006 on the principle of enhancing the delivery of healthcare to the ophthalmic market. It’s flagship product, Mitosol, was FDA approved in 2012 and received Medicare reimbursement in 2013. Building on the model of innovation by which Mobius was founded additional products are in development.

 

  • Ed has 30 years’ experience in the life-science industry. He has initiated and/or grown sub-specialty franchises for multiple companies, to include American Hospital Supply Corporation, Applied Medical Resources, Storz Ophthalmics, and Given Imaging, Ltd. He was previously responsible for Commercial Development at Synergetics, Inc., taking the company from start-up status to a M$40 public company, operating successfully in sixty countries and two surgical disciplines. Mr. Timm holds a B.A. degree in Philosophy from the University of Dayton and is the holder of fifteen issued US patents, ten international patents on four continents, with numerous patent applications pending.

    Ed Timm, CEO, President and Founder

  • Mr. Wright is a finance executive with significant experience in venture capital backed life science and technology companies. He has worked as a Chief Financial Officer and board member of several companies including BrainScope Company, Inc., Everest Biomedical Instruments Company, Inc., Abiliti Solutions, Inc. and Technology Applications, Inc. Mr. Wright began his finance career in public accounting including working for a Big Four accounting firm in the Accounting & Advisory Services group. Mr. Wright is a Certified Public Accountant and received his B.S.B.A from Saint Louis University.

    Mark Wright, CFO

  • Mr. Bishop joined Mobius Therapeutics in 2014 as VP of Sales and Marketing and is a sales and marketing executive with extensive experience in the commercial operations of life science companies including sales, marketing, managed markets, and sales operations. He has held a variety of leadership roles at Roche Diagnostics, Alcon Laboratories, and DuPont Pharmaceuticals. Mr. Bishop began his career as a research chemist before transitioning into the business side of the life science industry. Mr. Bishop received his MBA from the University of New Mexico and his BS in Biochemistry from the University of Texas at Austin.

    Owen Bishop, VP Sales & Marketing

  • Dr. Schwartz, a board certified Ophthalmologist, is a graduate of Bowdoin College and Jefferson Medical College. He completed his residency in Ophthalmology at Wills Eye Hospital in Philadelphia, and specializes in the treatment of Glaucoma. He has published a book: LASER THERAPY OF THE ANTERIOR SEGMENT, as well as several book chapters and numerous articles in peer reviewed journals. Dr. Schwartz has lectured extensively to fellow physicians locally, nationally, and internationally. He is an Emeritus Clinical Professor of Ophthalmology at Thomas Jefferson University and an Emeritus Attending Surgeon on the Glaucoma Service at Wills Eye Hospital where he is active in teaching residents. Dr. Schwartz is a member of the American Board of Ophthalmology, the American Glaucoma Society, and the College of Physicians of Philadelphia.

    Lou Schwartz, M.D. - Medical Director

  • Chris joined Mobius Therapeutics in 2017 as VP of Regulatory, Quality & Compliance with 30+ years’ experience in designing, maintaining and managing regulatory and quality systems for FDA regulated industries. Prior to Mobius, Chris worked for Alkem Laboratories as Sr. Director of Regulatory, Compliance & QA and Fleming Pharmaceuticals in several positions and increasing responsibility including Quality Specialist, Quality Assurance Manager, Project Manager and Regulatory Affairs Manager. She developed her quality management skills while working as a Quality Assurance Manager at LifeCell Corporation, Optex Biomedical, Inc. and as Microbiology Manager for Combe Laboratories, Inc. After receiving her B.S. in Biology from Illinois College, Chris began her career as a microbiologist and chemist.

    Chris Patullo, VP of Quality & Regulatory